CMF-01978 | PCDH9 | down-regulates | VDR | activates | R-232 | 14 | 4 | Drugs (60) Regulator Drugs (0)Regulon Drugs (60)INFLIXIMAB, MIDOSTAURIN, ATN-161, INTERFERON GAMMA-1B, ONERCEPT, BMS-986142, HM-71224, AME-133V, DASATINIB, MSC-2364447, PF-06651600, AMY-101, PEGSUNERCEPT, ABIVERTINIB, GOLIMUMAB, ABIVERTINIB MALEATE, MEDI-2338, EFALIZUMAB, ETANERCEPT, RILZABRUTINIB, AFELIMOMAB, SPEBRUTINIB, SOTRASTAURIN, OZORALIZUMAB, ILORASERTIB, CERTOLIZUMAB PEGOL, UCN-01, IBRUTINIB, TADEKINIG ALFA, PETESICATIB, PF-04605412, ZANUBRUTINIB, XL-228, EVOBRUTINIB, OTLERTUZUMAB, REMTOLUMAB, BI-836826, TG100-801, SPEBRUTINIB BESYLATE, PEGCETACOPLAN, POSELTINIB, LIFITEGRAST, PIRTOBRUTINIB, OCRIPLASMIN, ACALABRUTINIB, ADALIMUMAB, MILATUZUMAB, VOLOCIXIMAB, ELSUBRUTINIB, BRANEBRUTINIB, PLACULUMAB, TIRABRUTINIB, DELCASERTIB, FENEBRUTINIB, NARATUXIMAB EMTANSINE, GSK-690693, ORELABRUTINIB, GSK-1070806, AL-78898A, ENMD-981693 |
CMF-01979 | PCDH9 | down-regulates | VDR | activates | R-245 | 14 | 4 | Drugs (5) |
CMF-03101 | LAMA3 | down-regulates | VDR | activates | R-240 | 14 | 1 | Drugs (3) |
CMF-04582 | LAMC3 | down-regulates | VDR | activates | R-232 | 14 | 5 | Drugs (60) Regulator Drugs (0)Regulon Drugs (60)INFLIXIMAB, MIDOSTAURIN, ATN-161, INTERFERON GAMMA-1B, ONERCEPT, BMS-986142, HM-71224, AME-133V, DASATINIB, MSC-2364447, PF-06651600, AMY-101, PEGSUNERCEPT, ABIVERTINIB, GOLIMUMAB, ABIVERTINIB MALEATE, MEDI-2338, EFALIZUMAB, ETANERCEPT, RILZABRUTINIB, AFELIMOMAB, SPEBRUTINIB, SOTRASTAURIN, OZORALIZUMAB, ILORASERTIB, CERTOLIZUMAB PEGOL, UCN-01, IBRUTINIB, TADEKINIG ALFA, PETESICATIB, PF-04605412, ZANUBRUTINIB, XL-228, EVOBRUTINIB, OTLERTUZUMAB, REMTOLUMAB, BI-836826, TG100-801, SPEBRUTINIB BESYLATE, PEGCETACOPLAN, POSELTINIB, LIFITEGRAST, PIRTOBRUTINIB, OCRIPLASMIN, ACALABRUTINIB, ADALIMUMAB, MILATUZUMAB, VOLOCIXIMAB, ELSUBRUTINIB, BRANEBRUTINIB, PLACULUMAB, TIRABRUTINIB, DELCASERTIB, FENEBRUTINIB, NARATUXIMAB EMTANSINE, GSK-690693, ORELABRUTINIB, GSK-1070806, AL-78898A, ENMD-981693 |
CMF-04584 | LAMC3 | down-regulates | VDR | activates | R-240 | 14 | 5 | Drugs (3) |
CMF-04808 | SLC6A3 | down-regulates | VDR | activates | R-245 | 14 | 2 | Drugs (5) |
CMF-04958 | ABCC5 | down-regulates | VDR | activates | R-245 | 14 | 2 | Drugs (5) |
CMF-04998 | ODZ4 | down-regulates | VDR | activates | R-235 | 14 | 3 | Drugs (1) |
CMF-05173 | PLA2G4A | down-regulates | VDR | activates | R-245 | 14 | 1 | Drugs (5) |
CMF-05780 | ADAMTS19 | down-regulates | VDR | activates | R-245 | 14 | 2 | Drugs (5) |
CMF-06092 | FGFR3 | up-regulates | VDR | activates | R-232 | 14 | 4 | Drugs (60) Regulator Drugs (0)Regulon Drugs (60)INFLIXIMAB, MIDOSTAURIN, ATN-161, INTERFERON GAMMA-1B, ONERCEPT, BMS-986142, HM-71224, AME-133V, DASATINIB, MSC-2364447, PF-06651600, AMY-101, PEGSUNERCEPT, ABIVERTINIB, GOLIMUMAB, ABIVERTINIB MALEATE, MEDI-2338, EFALIZUMAB, ETANERCEPT, RILZABRUTINIB, AFELIMOMAB, SPEBRUTINIB, SOTRASTAURIN, OZORALIZUMAB, ILORASERTIB, CERTOLIZUMAB PEGOL, UCN-01, IBRUTINIB, TADEKINIG ALFA, PETESICATIB, PF-04605412, ZANUBRUTINIB, XL-228, EVOBRUTINIB, OTLERTUZUMAB, REMTOLUMAB, BI-836826, TG100-801, SPEBRUTINIB BESYLATE, PEGCETACOPLAN, POSELTINIB, LIFITEGRAST, PIRTOBRUTINIB, OCRIPLASMIN, ACALABRUTINIB, ADALIMUMAB, MILATUZUMAB, VOLOCIXIMAB, ELSUBRUTINIB, BRANEBRUTINIB, PLACULUMAB, TIRABRUTINIB, DELCASERTIB, FENEBRUTINIB, NARATUXIMAB EMTANSINE, GSK-690693, ORELABRUTINIB, GSK-1070806, AL-78898A, ENMD-981693 |
CMF-06093 | FGFR3 | up-regulates | VDR | activates | R-240 | 14 | 4 | Drugs (3) |
CMF-07041 | ATRX | down-regulates | VDR | activates | R-245 | 14 | 7 | Drugs (5) |
CMF-07043 | ATRX | down-regulates | VDR | activates | R-240 | 14 | 7 | Drugs (3) |
CMF-07581 | AHNAK2 | down-regulates | VDR | activates | R-232 | 14 | 4 | Drugs (60) Regulator Drugs (0)Regulon Drugs (60)INFLIXIMAB, MIDOSTAURIN, ATN-161, INTERFERON GAMMA-1B, ONERCEPT, BMS-986142, HM-71224, AME-133V, DASATINIB, MSC-2364447, PF-06651600, AMY-101, PEGSUNERCEPT, ABIVERTINIB, GOLIMUMAB, ABIVERTINIB MALEATE, MEDI-2338, EFALIZUMAB, ETANERCEPT, RILZABRUTINIB, AFELIMOMAB, SPEBRUTINIB, SOTRASTAURIN, OZORALIZUMAB, ILORASERTIB, CERTOLIZUMAB PEGOL, UCN-01, IBRUTINIB, TADEKINIG ALFA, PETESICATIB, PF-04605412, ZANUBRUTINIB, XL-228, EVOBRUTINIB, OTLERTUZUMAB, REMTOLUMAB, BI-836826, TG100-801, SPEBRUTINIB BESYLATE, PEGCETACOPLAN, POSELTINIB, LIFITEGRAST, PIRTOBRUTINIB, OCRIPLASMIN, ACALABRUTINIB, ADALIMUMAB, MILATUZUMAB, VOLOCIXIMAB, ELSUBRUTINIB, BRANEBRUTINIB, PLACULUMAB, TIRABRUTINIB, DELCASERTIB, FENEBRUTINIB, NARATUXIMAB EMTANSINE, GSK-690693, ORELABRUTINIB, GSK-1070806, AL-78898A, ENMD-981693 |
CMF-08078 | TRIM6-TRIM34 | down-regulates | VDR | activates | R-232 | 14 | 1 | Drugs (60) Regulator Drugs (0)Regulon Drugs (60)INFLIXIMAB, MIDOSTAURIN, ATN-161, INTERFERON GAMMA-1B, ONERCEPT, BMS-986142, HM-71224, AME-133V, DASATINIB, MSC-2364447, PF-06651600, AMY-101, PEGSUNERCEPT, ABIVERTINIB, GOLIMUMAB, ABIVERTINIB MALEATE, MEDI-2338, EFALIZUMAB, ETANERCEPT, RILZABRUTINIB, AFELIMOMAB, SPEBRUTINIB, SOTRASTAURIN, OZORALIZUMAB, ILORASERTIB, CERTOLIZUMAB PEGOL, UCN-01, IBRUTINIB, TADEKINIG ALFA, PETESICATIB, PF-04605412, ZANUBRUTINIB, XL-228, EVOBRUTINIB, OTLERTUZUMAB, REMTOLUMAB, BI-836826, TG100-801, SPEBRUTINIB BESYLATE, PEGCETACOPLAN, POSELTINIB, LIFITEGRAST, PIRTOBRUTINIB, OCRIPLASMIN, ACALABRUTINIB, ADALIMUMAB, MILATUZUMAB, VOLOCIXIMAB, ELSUBRUTINIB, BRANEBRUTINIB, PLACULUMAB, TIRABRUTINIB, DELCASERTIB, FENEBRUTINIB, NARATUXIMAB EMTANSINE, GSK-690693, ORELABRUTINIB, GSK-1070806, AL-78898A, ENMD-981693 |
CMF-09282 | RP1 | down-regulates | VDR | activates | R-245 | 14 | 5 | Drugs (5) |
CMF-09284 | RP1 | down-regulates | VDR | activates | R-240 | 14 | 5 | Drugs (3) |
CMF-09967 | FBN1 | down-regulates | VDR | activates | R-232 | 14 | 4 | Drugs (60) Regulator Drugs (0)Regulon Drugs (60)INFLIXIMAB, MIDOSTAURIN, ATN-161, INTERFERON GAMMA-1B, ONERCEPT, BMS-986142, HM-71224, AME-133V, DASATINIB, MSC-2364447, PF-06651600, AMY-101, PEGSUNERCEPT, ABIVERTINIB, GOLIMUMAB, ABIVERTINIB MALEATE, MEDI-2338, EFALIZUMAB, ETANERCEPT, RILZABRUTINIB, AFELIMOMAB, SPEBRUTINIB, SOTRASTAURIN, OZORALIZUMAB, ILORASERTIB, CERTOLIZUMAB PEGOL, UCN-01, IBRUTINIB, TADEKINIG ALFA, PETESICATIB, PF-04605412, ZANUBRUTINIB, XL-228, EVOBRUTINIB, OTLERTUZUMAB, REMTOLUMAB, BI-836826, TG100-801, SPEBRUTINIB BESYLATE, PEGCETACOPLAN, POSELTINIB, LIFITEGRAST, PIRTOBRUTINIB, OCRIPLASMIN, ACALABRUTINIB, ADALIMUMAB, MILATUZUMAB, VOLOCIXIMAB, ELSUBRUTINIB, BRANEBRUTINIB, PLACULUMAB, TIRABRUTINIB, DELCASERTIB, FENEBRUTINIB, NARATUXIMAB EMTANSINE, GSK-690693, ORELABRUTINIB, GSK-1070806, AL-78898A, ENMD-981693 |
CMF-09968 | FBN1 | down-regulates | VDR | activates | R-240 | 14 | 4 | Drugs (3) |
CMF-10010 | ALB | up-regulates | VDR | activates | R-232 | 14 | 2 | Drugs (60) Regulator Drugs (0)Regulon Drugs (60)INFLIXIMAB, MIDOSTAURIN, ATN-161, INTERFERON GAMMA-1B, ONERCEPT, BMS-986142, HM-71224, AME-133V, DASATINIB, MSC-2364447, PF-06651600, AMY-101, PEGSUNERCEPT, ABIVERTINIB, GOLIMUMAB, ABIVERTINIB MALEATE, MEDI-2338, EFALIZUMAB, ETANERCEPT, RILZABRUTINIB, AFELIMOMAB, SPEBRUTINIB, SOTRASTAURIN, OZORALIZUMAB, ILORASERTIB, CERTOLIZUMAB PEGOL, UCN-01, IBRUTINIB, TADEKINIG ALFA, PETESICATIB, PF-04605412, ZANUBRUTINIB, XL-228, EVOBRUTINIB, OTLERTUZUMAB, REMTOLUMAB, BI-836826, TG100-801, SPEBRUTINIB BESYLATE, PEGCETACOPLAN, POSELTINIB, LIFITEGRAST, PIRTOBRUTINIB, OCRIPLASMIN, ACALABRUTINIB, ADALIMUMAB, MILATUZUMAB, VOLOCIXIMAB, ELSUBRUTINIB, BRANEBRUTINIB, PLACULUMAB, TIRABRUTINIB, DELCASERTIB, FENEBRUTINIB, NARATUXIMAB EMTANSINE, GSK-690693, ORELABRUTINIB, GSK-1070806, AL-78898A, ENMD-981693 |
CMF-12347 | GPR98 | down-regulates | VDR | activates | R-245 | 14 | 8 | Drugs (5) |
CMF-12349 | GPR98 | down-regulates | VDR | activates | R-240 | 14 | 8 | Drugs (3) |
CMF-12353 | GPR98 | down-regulates | VDR | activates | R-235 | 14 | 8 | Drugs (1) |
CMF-12772 | NTN4 | down-regulates | VDR | activates | R-245 | 14 | 1 | Drugs (5) |
CMF-13282 | SULF2 | down-regulates | VDR | activates | R-245 | 14 | 3 | Drugs (5) |
CMF-13283 | SULF2 | down-regulates | VDR | activates | R-240 | 14 | 3 | Drugs (3) |
CMF-13847 | ADAMTS8 | down-regulates | VDR | activates | R-232 | 14 | 6 | Drugs (60) Regulator Drugs (0)Regulon Drugs (60)INFLIXIMAB, MIDOSTAURIN, ATN-161, INTERFERON GAMMA-1B, ONERCEPT, BMS-986142, HM-71224, AME-133V, DASATINIB, MSC-2364447, PF-06651600, AMY-101, PEGSUNERCEPT, ABIVERTINIB, GOLIMUMAB, ABIVERTINIB MALEATE, MEDI-2338, EFALIZUMAB, ETANERCEPT, RILZABRUTINIB, AFELIMOMAB, SPEBRUTINIB, SOTRASTAURIN, OZORALIZUMAB, ILORASERTIB, CERTOLIZUMAB PEGOL, UCN-01, IBRUTINIB, TADEKINIG ALFA, PETESICATIB, PF-04605412, ZANUBRUTINIB, XL-228, EVOBRUTINIB, OTLERTUZUMAB, REMTOLUMAB, BI-836826, TG100-801, SPEBRUTINIB BESYLATE, PEGCETACOPLAN, POSELTINIB, LIFITEGRAST, PIRTOBRUTINIB, OCRIPLASMIN, ACALABRUTINIB, ADALIMUMAB, MILATUZUMAB, VOLOCIXIMAB, ELSUBRUTINIB, BRANEBRUTINIB, PLACULUMAB, TIRABRUTINIB, DELCASERTIB, FENEBRUTINIB, NARATUXIMAB EMTANSINE, GSK-690693, ORELABRUTINIB, GSK-1070806, AL-78898A, ENMD-981693 |
CMF-13848 | ADAMTS8 | down-regulates | VDR | activates | R-245 | 14 | 6 | Drugs (5) |
CMF-13850 | ADAMTS8 | down-regulates | VDR | activates | R-240 | 14 | 6 | Drugs (3) |
CMF-14635 | C1orf177 | up-regulates | VDR | activates | R-232 | 14 | 2 | Drugs (60) Regulator Drugs (0)Regulon Drugs (60)INFLIXIMAB, MIDOSTAURIN, ATN-161, INTERFERON GAMMA-1B, ONERCEPT, BMS-986142, HM-71224, AME-133V, DASATINIB, MSC-2364447, PF-06651600, AMY-101, PEGSUNERCEPT, ABIVERTINIB, GOLIMUMAB, ABIVERTINIB MALEATE, MEDI-2338, EFALIZUMAB, ETANERCEPT, RILZABRUTINIB, AFELIMOMAB, SPEBRUTINIB, SOTRASTAURIN, OZORALIZUMAB, ILORASERTIB, CERTOLIZUMAB PEGOL, UCN-01, IBRUTINIB, TADEKINIG ALFA, PETESICATIB, PF-04605412, ZANUBRUTINIB, XL-228, EVOBRUTINIB, OTLERTUZUMAB, REMTOLUMAB, BI-836826, TG100-801, SPEBRUTINIB BESYLATE, PEGCETACOPLAN, POSELTINIB, LIFITEGRAST, PIRTOBRUTINIB, OCRIPLASMIN, ACALABRUTINIB, ADALIMUMAB, MILATUZUMAB, VOLOCIXIMAB, ELSUBRUTINIB, BRANEBRUTINIB, PLACULUMAB, TIRABRUTINIB, DELCASERTIB, FENEBRUTINIB, NARATUXIMAB EMTANSINE, GSK-690693, ORELABRUTINIB, GSK-1070806, AL-78898A, ENMD-981693 |
CMF-15156 | YEATS2 | down-regulates | VDR | activates | R-232 | 14 | 5 | Drugs (60) Regulator Drugs (0)Regulon Drugs (60)INFLIXIMAB, MIDOSTAURIN, ATN-161, INTERFERON GAMMA-1B, ONERCEPT, BMS-986142, HM-71224, AME-133V, DASATINIB, MSC-2364447, PF-06651600, AMY-101, PEGSUNERCEPT, ABIVERTINIB, GOLIMUMAB, ABIVERTINIB MALEATE, MEDI-2338, EFALIZUMAB, ETANERCEPT, RILZABRUTINIB, AFELIMOMAB, SPEBRUTINIB, SOTRASTAURIN, OZORALIZUMAB, ILORASERTIB, CERTOLIZUMAB PEGOL, UCN-01, IBRUTINIB, TADEKINIG ALFA, PETESICATIB, PF-04605412, ZANUBRUTINIB, XL-228, EVOBRUTINIB, OTLERTUZUMAB, REMTOLUMAB, BI-836826, TG100-801, SPEBRUTINIB BESYLATE, PEGCETACOPLAN, POSELTINIB, LIFITEGRAST, PIRTOBRUTINIB, OCRIPLASMIN, ACALABRUTINIB, ADALIMUMAB, MILATUZUMAB, VOLOCIXIMAB, ELSUBRUTINIB, BRANEBRUTINIB, PLACULUMAB, TIRABRUTINIB, DELCASERTIB, FENEBRUTINIB, NARATUXIMAB EMTANSINE, GSK-690693, ORELABRUTINIB, GSK-1070806, AL-78898A, ENMD-981693 |
CMF-15158 | YEATS2 | down-regulates | VDR | activates | R-240 | 14 | 5 | Drugs (3) |
CMF-16245 | USP11 | down-regulates | VDR | activates | R-240 | 14 | 3 | Drugs (3) |
CMF-16246 | USP11 | down-regulates | VDR | activates | R-235 | 14 | 3 | Drugs (1) |
CMF-17908 | CYLC2 | down-regulates | VDR | activates | R-245 | 14 | 2 | Drugs (5) |
CMF-17909 | CYLC2 | down-regulates | VDR | activates | R-240 | 14 | 2 | Drugs (3) |
CMF-20140 | TDRD9 | up-regulates | VDR | activates | R-232 | 14 | 4 | Drugs (60) Regulator Drugs (0)Regulon Drugs (60)INFLIXIMAB, MIDOSTAURIN, ATN-161, INTERFERON GAMMA-1B, ONERCEPT, BMS-986142, HM-71224, AME-133V, DASATINIB, MSC-2364447, PF-06651600, AMY-101, PEGSUNERCEPT, ABIVERTINIB, GOLIMUMAB, ABIVERTINIB MALEATE, MEDI-2338, EFALIZUMAB, ETANERCEPT, RILZABRUTINIB, AFELIMOMAB, SPEBRUTINIB, SOTRASTAURIN, OZORALIZUMAB, ILORASERTIB, CERTOLIZUMAB PEGOL, UCN-01, IBRUTINIB, TADEKINIG ALFA, PETESICATIB, PF-04605412, ZANUBRUTINIB, XL-228, EVOBRUTINIB, OTLERTUZUMAB, REMTOLUMAB, BI-836826, TG100-801, SPEBRUTINIB BESYLATE, PEGCETACOPLAN, POSELTINIB, LIFITEGRAST, PIRTOBRUTINIB, OCRIPLASMIN, ACALABRUTINIB, ADALIMUMAB, MILATUZUMAB, VOLOCIXIMAB, ELSUBRUTINIB, BRANEBRUTINIB, PLACULUMAB, TIRABRUTINIB, DELCASERTIB, FENEBRUTINIB, NARATUXIMAB EMTANSINE, GSK-690693, ORELABRUTINIB, GSK-1070806, AL-78898A, ENMD-981693 |
CMF-20601 | ADCY1 | up-regulates | VDR | activates | R-245 | 14 | 2 | Drugs (5) |
CMF-21466 | IL4R | down-regulates | VDR | activates | R-245 | 14 | 3 | Drugs (5) |
CMF-21468 | IL4R | down-regulates | VDR | activates | R-235 | 14 | 3 | Drugs (1) |
CMF-22116 | OR2T34 | down-regulates | VDR | activates | R-245 | 14 | 1 | Drugs (5) |
CMF-22161 | PDGFRA | down-regulates | VDR | activates | R-245 | 14 | 4 | Drugs (5) |
CMF-22162 | PDGFRA | down-regulates | VDR | activates | R-240 | 14 | 4 | Drugs (3) |
CMF-22792 | IDH1 | down-regulates | VDR | activates | R-245 | 14 | 10 | Drugs (5) |
CMF-22794 | IDH1 | down-regulates | VDR | activates | R-240 | 14 | 10 | Drugs (3) |
CMF-22797 | IDH1 | down-regulates | VDR | activates | R-235 | 14 | 10 | Drugs (1) |
CMF-23085 | PDHA2 | down-regulates | VDR | activates | R-245 | 14 | 1 | Drugs (5) |
CMF-25072 | IQSEC3 | down-regulates | VDR | activates | R-245 | 14 | 5 | Drugs (5) |
CMF-25073 | IQSEC3 | down-regulates | VDR | activates | R-240 | 14 | 5 | Drugs (3) |
CMF-25348 | PARG | down-regulates | VDR | activates | R-245 | 14 | 1 | Drugs (5) |
CMF-26279 | CEP250 | down-regulates | VDR | activates | R-240 | 14 | 3 | Drugs (3) |
CMF-26650 | C5AR1 | down-regulates | VDR | activates | R-245 | 14 | 1 | Drugs (5) |
CMF-28104 | CELSR3 | down-regulates | VDR | activates | R-245 | 14 | 5 | Drugs (5) |
CMF-28106 | CELSR3 | down-regulates | VDR | activates | R-240 | 14 | 5 | Drugs (3) |
CMF-28108 | CELSR3 | down-regulates | VDR | activates | R-235 | 14 | 5 | Drugs (1) |
CMF-28232 | REPIN1 | up-regulates | VDR | activates | R-240 | 14 | 3 | Drugs (3) |
CMF-28436 | MYO9B | down-regulates | VDR | activates | R-245 | 14 | 5 | Drugs (5) |
CMF-28438 | MYO9B | down-regulates | VDR | activates | R-240 | 14 | 5 | Drugs (3) |
CMF-28661 | PCNX | down-regulates | VDR | activates | R-245 | 14 | 3 | Drugs (5) |
CMF-28662 | PCNX | down-regulates | VDR | activates | R-240 | 14 | 3 | Drugs (3) |
CMF-28663 | PCNX | down-regulates | VDR | activates | R-235 | 14 | 3 | Drugs (1) |
CMF-29231 | AQP10 | down-regulates | VDR | activates | R-240 | 14 | 1 | Drugs (3) |
CMF-30333 | SPINT1 | down-regulates | VDR | activates | R-240 | 14 | 1 | Drugs (3) |
CMF-30492 | PROKR2 | down-regulates | VDR | activates | R-232 | 14 | 4 | Drugs (60) Regulator Drugs (0)Regulon Drugs (60)INFLIXIMAB, MIDOSTAURIN, ATN-161, INTERFERON GAMMA-1B, ONERCEPT, BMS-986142, HM-71224, AME-133V, DASATINIB, MSC-2364447, PF-06651600, AMY-101, PEGSUNERCEPT, ABIVERTINIB, GOLIMUMAB, ABIVERTINIB MALEATE, MEDI-2338, EFALIZUMAB, ETANERCEPT, RILZABRUTINIB, AFELIMOMAB, SPEBRUTINIB, SOTRASTAURIN, OZORALIZUMAB, ILORASERTIB, CERTOLIZUMAB PEGOL, UCN-01, IBRUTINIB, TADEKINIG ALFA, PETESICATIB, PF-04605412, ZANUBRUTINIB, XL-228, EVOBRUTINIB, OTLERTUZUMAB, REMTOLUMAB, BI-836826, TG100-801, SPEBRUTINIB BESYLATE, PEGCETACOPLAN, POSELTINIB, LIFITEGRAST, PIRTOBRUTINIB, OCRIPLASMIN, ACALABRUTINIB, ADALIMUMAB, MILATUZUMAB, VOLOCIXIMAB, ELSUBRUTINIB, BRANEBRUTINIB, PLACULUMAB, TIRABRUTINIB, DELCASERTIB, FENEBRUTINIB, NARATUXIMAB EMTANSINE, GSK-690693, ORELABRUTINIB, GSK-1070806, AL-78898A, ENMD-981693 |
CMF-30493 | PROKR2 | down-regulates | VDR | activates | R-245 | 14 | 4 | Drugs (5) |
CMF-31169 | LRFN2 | down-regulates | VDR | activates | R-232 | 14 | 5 | Drugs (60) Regulator Drugs (0)Regulon Drugs (60)INFLIXIMAB, MIDOSTAURIN, ATN-161, INTERFERON GAMMA-1B, ONERCEPT, BMS-986142, HM-71224, AME-133V, DASATINIB, MSC-2364447, PF-06651600, AMY-101, PEGSUNERCEPT, ABIVERTINIB, GOLIMUMAB, ABIVERTINIB MALEATE, MEDI-2338, EFALIZUMAB, ETANERCEPT, RILZABRUTINIB, AFELIMOMAB, SPEBRUTINIB, SOTRASTAURIN, OZORALIZUMAB, ILORASERTIB, CERTOLIZUMAB PEGOL, UCN-01, IBRUTINIB, TADEKINIG ALFA, PETESICATIB, PF-04605412, ZANUBRUTINIB, XL-228, EVOBRUTINIB, OTLERTUZUMAB, REMTOLUMAB, BI-836826, TG100-801, SPEBRUTINIB BESYLATE, PEGCETACOPLAN, POSELTINIB, LIFITEGRAST, PIRTOBRUTINIB, OCRIPLASMIN, ACALABRUTINIB, ADALIMUMAB, MILATUZUMAB, VOLOCIXIMAB, ELSUBRUTINIB, BRANEBRUTINIB, PLACULUMAB, TIRABRUTINIB, DELCASERTIB, FENEBRUTINIB, NARATUXIMAB EMTANSINE, GSK-690693, ORELABRUTINIB, GSK-1070806, AL-78898A, ENMD-981693 |